PMID: 10653923Feb 2, 2000

Dyslipidemia and coronary artery disease

The Canadian Journal of Cardiology
J G Genest

Abstract

Atherosclerotic vascular diseases are expected to remain the major cause of mortality and morbidity globally well into the 21st century. Preventive measures by lifestyle changes (diet, exercise, smoking cessation, prevention of obesity and diabetes) will play an important role in retarding the onset of these diseases. A strategy aimed at identifying high risk individuals - those with established coronary artery disease or other vascular diseases - will provide the most cost effective means of preventing cardiovascular events. The high risk strategy is aimed at identification of healthy subjects with multiple cardiovascular risk factors, identification of those with diabetes, identification of those with genetic lipoprotein disorders and initiation of treatment with medications if necessary. Categorical risk factors should be treated because of the lifetime increase in cardiovascular risk.

Related Concepts

Morbidity Aspects
Coronary Artery Disease
Transcription Initiation
Coronary Arteriosclerosis
Dyslipidemias
Hypolipidemic Agents
Carotid Artery Diseases
Vascular Diseases
High Density Lipoprotein Cholesterol
Lipoproteins

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Koichi Node
Postgraduate Medicine
R ZelisB H Roberts
Clinical Epidemiology
B Ng JustinAntoine M Hakim
Annals of the New York Academy of Sciences
Sataro GotoRyoichi Abea
© 2020 Meta ULC. All rights reserved